Bio-Gate Balance Sheet Health
Financial Health criteria checks 4/6
Bio-Gate has a total shareholder equity of €3.5M and total debt of €417.0K, which brings its debt-to-equity ratio to 12.1%. Its total assets and total liabilities are €5.3M and €1.8M respectively.
Key information
12.1%
Debt to equity ratio
€417.00k
Debt
Interest coverage ratio | n/a |
Cash | €1.33m |
Equity | €3.45m |
Total liabilities | €1.81m |
Total assets | €5.26m |
Recent financial health updates
No updates
Recent updates
No updates
Financial Position Analysis
Short Term Liabilities: BIG1's short term assets (€3.3M) exceed its short term liabilities (€1.6M).
Long Term Liabilities: BIG1's short term assets (€3.3M) exceed its long term liabilities (€188.8K).
Debt to Equity History and Analysis
Debt Level: BIG1 has more cash than its total debt.
Reducing Debt: BIG1's debt to equity ratio has increased from 9.7% to 12.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BIG1 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if BIG1 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.